DD news

DuPont reported strong Q3 2026 results with organic sales increasing 5% and adjusted EPS of $2.09, up 62%. The company significantly raised its full-year 2026 guidance and executed on capital allocation.

DuPont and Corteva agreed to provide financial assurance for Chemours' PFAS liabilities. This regulatory settlement could impact future cash flows and financial metrics for the companies involved while resolving significant legal and environmental obligations.

DuPont reported strong Q2 2026 results with net sales up 4% and EPS exceeding guidance. The company also raised its full year financial outlook and announced a $250 million share repurchase program.

DuPont stockholders approved an amendment to the charter to a 1-for-3 reverse stock split, converting three shares into one. The company will distribute cash for fractional interests related to the conversion.

DuPont's Board approved a reverse stock split at a 1-for-3 ratio, reducing outstanding shares from ~405 million to ~135 million and authorized shares from 1.67 billion to 556 million. The company reaffirmed 2026 financial guidance with split-adjusted EPS metrics, resulting in higher per-share figure…